Ledger.Open graph →
SEC Form D · Amendment · filed September 17, 2020

Genomind, Inc

Offering
$21.7M
Sold
$20.6M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
King of Prussia, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

Thomas E. Hess · King of Prussia, PAExecTheresa E. Sexton · Nashville, TNDirectorJoseph E. Anton · Boston, MADirectorJohn E. Chadwick · Nashville, TNDirectorShawn P. O'Brien · King of Prussia, PAExec · DirectorKip P. Olmstead · King of Prussia, PAExecGloria E. Nuss · Norfolk, VAExecStephen E. Haller · Norfolk, VAExecBrad P. Lucas · Boston, MADirectorBarden Gale · New York, NYExecDouglas B. Dunn · Houston, TXDirectorRail-Splitter Capital Management, LLC · Chicago, ILDirectorMichael Mcgillis · New York, NYExec · DirectorPCM Capital Select Managers Fund LLC · Kansas City, MODirectorRobert A. Dean · OMAHA, NEExec · DirectorDouglas L. Dethy · New York, NYExec · DirectorPCM Capital Managed Equity Fund I LLC · Kansas City, MOExecAugusto Alvarez · Santa Fe, O5ExecDavid Riker · New York, NYDirectorJonathan Budd · DEL MAR, CAExecMitchell B. Kleinhandler · ATLANTA, GAExecDavid B. Citron · ATLANTA, GAExec · DirectorBrad P. Lucas · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗